Publication Name	World Journal of Clinical Oncology
Manuscript ID	31937
Country	India

Received	2016-12-16 08:48
Peer-Review Started	2016-12-19 10:50
To Make the First Decision	2017-03-27 11:53
Return for Revision	2017-03-28 16:56
Revised	2017-04-01 15:20
Second Decision	2017-05-02 11:08
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-05-15 04:02
Articles in Press	2017-05-15 04:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-05-26 04:58
Publish the Manuscript Online	2017-06-02 05:29

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
Manuscript Source	Invited Manuscript
All Author List	Shefali Agrawal
Funding Agency and Grant Number
Corresponding Author	Shefali Agrawal, MD, MS, FACS, Senior Consultant, Hepatobiliary and Pancreatic Surgery, Department of Surgical Oncology, Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi 110076, India. shefali_a@apollohospitals.com
Key Words	Prognostic biomarkers; Pancreatic juice; Bile; Pancreatic adenocarcinoma; Surgery
Core Tip	Pancreatic juice is a rich source of cancer-specific proteins rendering it a promising tool for identifying novel biomarkers in pancreatic ductal adenocarcinoma. Recent proteomic and microRNA expression analyses have identified several diagnostic and prognostic biomarkers. Elevated carcinoembryonic antigen (CEA) in bile is a marker of malignancy and a predictor of hepatic recurrence. The potential of cancer antigen 19-9, CEA and lactate dehydrogenase as prognostic biomarkers in pancreatic juice and bile is unknown. Specimens of pancreatic juice and bile can be readily collected during pancreatic resection. Profiling of pancreatic juice and bile to identify novel biomarkers may facilitate early diagnosis and improve selection of patients for adjuvant therapy.
Publish Date	2017-06-02 05:29
Citation	Agrawal S. Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma. World J Clin Oncol 2017; 8(3): 255-260
URL	http://www.wjgnet.com/2218-4333/full/v8/i3/255.htm
DOI	http://dx.doi.org/10.5306/wjco.v8.i3.255

Full Article (PDF)	WJCO-8-255.pdf
Full Article (Word)	WJCO-8-255.doc
Manuscript File	31937-Review.doc
Answering Reviewers	31937-Answering reviewers.pdf
Audio Core Tip	31937-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	31937-Conflict-of-interest statement.pdf
Copyright License Agreement	31937-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	31937-Language certificate.pdf
Peer-review Report	31937-Peer-review(s).pdf
Scientific Misconduct Check	31937-Scientific misconduct check.pdf
Scientific Editor Work List	31937-Scientific editor work list.pdf